Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|December 20, 2007
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysisGabriel Rogers, Ruth Garside, Stuart Mealing, et al.
MDM Policy & Practice|June 29, 2026
A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of MelanomaRob Hainsworth, Louisa Collins, Martin Eden, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 10, 2024
Detection and Coil Embolisation of Pelvic Vein Incompetence for Chronic Pain in the Female Pelvis: A Development Phase Economic AnalysisRob Hainsworth, Martin Eden, Jonathan Ghosh, et al.
Pharmacoeconomics|July 8, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling MethodsThomas S Clemmet, Duc Binh Phan, Alice Copson, et al.
BMJ Open|September 21, 2023
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UKAlexander Thompson, Ji-Hee Youn, Bruce Guthrie, et al.
Age and Ageing|November 27, 2012
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic modelChristopher Hyde, Jaime Peters, Mary Bond, et al.
BMJ Public Health|July 15, 2026
Proactive case-finding and risk-stratification in people at risk of chronic liver disease in Greater Manchester: a cost-effectiveness analysisGabriel Rogers, Stephanie Landi, Huw Purssell, et al.
Health and Social Care Delivery Research|February 29, 2024
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysisBruce Guthrie, Gabriel Rogers, Shona Livingstone, et al.
NIHR Open Research|August 14, 2024
Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocolLibby Sadler, Hayley Jones, Penny Whiting, et al.
BMJ (Clinical Research Ed.)|July 24, 2024
Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling studyElizabeth M Camacho, Leonie S Penner, Amy Taylor, et al.
Pageof 3